1. Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma. Issue 9 (November 2018) Authors: Tavera, René J.; Forget, Marie-Andrée; Kim, Young Uk; Sakellariou-Thompson, Donastas; Creasy, Caitlin A.; Bhatta, Ankit; Fulbright, Orenthial J.; Ramachandran, Renjith; Thorsen, Shawne T.; Flores, Esteban; Wahl, Arely; Gonzalez, Audrey M.; Toth, Christopher; Wardell, Seth; Mansaray, Rahmatu; Radv... Journal: Journal of immunotherapy Issue: Volume 41:Issue 9(2018:Nov./Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗